These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22014542)

  • 21. Lipoxins: endogenous regulators of inflammation.
    McMahon B; Godson C
    Am J Physiol Renal Physiol; 2004 Feb; 286(2):F189-201. PubMed ID: 14707005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoxin a4 increases survival by decreasing systemic inflammation and bacterial load in sepsis.
    Walker J; Dichter E; Lacorte G; Kerner D; Spur B; Rodriguez A; Yin K
    Shock; 2011 Oct; 36(4):410-6. PubMed ID: 21701419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins.
    Petasis NA; Akritopoulou-Zanze I; Fokin VV; Bernasconi G; Keledjian R; Yang R; Uddin J; Nagulapalli KC; Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):301-21. PubMed ID: 16098719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesis.
    Thapa D; Lee JS; Heo SW; Lee YR; Kang KW; Kwak MK; Choi HG; Kim JA
    Eur J Pharmacol; 2011 Jan; 650(1):64-71. PubMed ID: 20950604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
    Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
    Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer stem cells: a step toward the cure.
    Boman BM; Wicha MS
    J Clin Oncol; 2008 Jun; 26(17):2795-9. PubMed ID: 18539956
    [No Abstract]   [Full Text] [Related]  

  • 27. Advances in thymosin beta10 research: differential expression, molecular mechanisms, and clinical implications in cancer and other conditions.
    Sribenja S; Li M; Wongkham S; Wongkham C; Yao Q; Chen C
    Cancer Invest; 2009 Dec; 27(10):1016-22. PubMed ID: 19909017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of invasion and experimental metastasis of murine melanoma cells by Ipomoea obscura (L.) is mediated through the down-regulation of inflammatory mediators and matrix-metalloproteinases.
    Hamsa TP; Kuttan G
    J Exp Ther Oncol; 2011; 9(2):139-51. PubMed ID: 21699021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of inflammatory cells and mediators in tumor invasion and metastasis.
    Mantovani A
    Cancer Metastasis Rev; 2010 Jun; 29(2):241. PubMed ID: 20397039
    [No Abstract]   [Full Text] [Related]  

  • 30. [Lipoxins--new view on old mediators carrying potent anti-inflammatory action].
    Jarmakowska K; Kuna P
    Pol Merkur Lekarski; 2005 May; 18(107):491-5. PubMed ID: 16161940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoxins and synthetic lipoxin mimetics: Therapeutic potential in renal diseases.
    Andrews D; Godson C
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Aug; 1866(8):158940. PubMed ID: 33839296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoxins as biomarkers of lupus and other inflammatory conditions.
    Das UN
    Lipids Health Dis; 2011 May; 10():76. PubMed ID: 21569625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depletion of regulatory T cells facilitates growth of established tumors: a mechanism involving the regulation of myeloid-derived suppressor cells by lipoxin A4.
    Zhang B; Jia H; Liu J; Yang Z; Jiang T; Tang K; Li D; Huang C; Ma J; Shen GX; Ye D; Huang B
    J Immunol; 2010 Dec; 185(12):7199-206. PubMed ID: 21068404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale.
    Calder PC
    Biochimie; 2009 Jun; 91(6):791-5. PubMed ID: 19455748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammation-mediated promotion of invasion and metastasis.
    Solinas G; Marchesi F; Garlanda C; Mantovani A; Allavena P
    Cancer Metastasis Rev; 2010 Jun; 29(2):243-8. PubMed ID: 20414701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
    Hakomori S
    Cancer Res; 1996 Dec; 56(23):5309-18. PubMed ID: 8968075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survivin gene RNA interference inhibits proliferation, induces apoptosis, and enhances radiosensitivity in HeLa cells.
    Song H; Xin XY; Xiao F; Wang DT; Yue QH; Han X
    Eur J Obstet Gynecol Reprod Biol; 2008 Jan; 136(1):83-9. PubMed ID: 17098350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene.
    Pietras RJ; Poen JC; Gallardo D; Wongvipat PN; Lee HJ; Slamon DJ
    Cancer Res; 1999 Mar; 59(6):1347-55. PubMed ID: 10096569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics.
    Serhan CN; Chiang N
    Rheum Dis Clin North Am; 2004 Feb; 30(1):69-95. PubMed ID: 15061569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoxins and new lipid mediators in the resolution of inflammation.
    Schwab JM; Serhan CN
    Curr Opin Pharmacol; 2006 Aug; 6(4):414-20. PubMed ID: 16750421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.